Hubei Kornnac Pharmaceutical: Advancing Global Health Through Quality APIs and CDMO Solutions
Hubei Kornnac Pharmaceutical stands as a trusted name in the global pharmaceutical supply chain, delivering high-quality active ingredients and intermediates to clients worldwide. With a strong commitment to research-driven manufacturing and international quality standards, the company serves diverse markets across Europe, Asia, and the Americas.
Company Overview and Strategic Positioning
Founded to disrupt traditional markets, the company has rapidly evolved into a leading force by prioritizing customer-centric innovation and operational agility. Its strategic positioning hinges on a dual approach: dominating niche segments through hyper-specialized solutions while simultaneously scaling a robust digital ecosystem. By leveraging data-driven insights and forming key strategic alliances, the brand effectively bridges the gap between legacy reliability and modern speed. This forward-thinking framework not only mitigates market volatility but also ensures sustained competitive advantage, positioning the firm as a premier choice for stakeholders seeking resilient growth.
Founding History and Corporate Milestones
Driven by a bold vision, the company has rapidly evolved into a market leader, delivering innovative solutions that redefine industry standards. Its strategic positioning centers on agility, customer-centricity, and sustainable growth, allowing it to outperform competitors across diverse markets. By leveraging cutting-edge technology and a talented workforce, the business consistently anticipates customer needs and adapts to shifting trends. This proactive approach not only strengthens brand loyalty but also expands its global footprint. Consequently, the organization remains well-equipped to capture new opportunities, drive long-term value, and maintain a resilient competitive advantage in an ever-changing economic landscape.
Leadership Team and Organizational Structure
Our company stands as a market leader in delivering innovative solutions tailored to evolving client needs. With a robust strategic positioning framework, we prioritize operational excellence, customer-centric innovation, and sustainable growth. Our competitive edge rests on three pillars:
- Agile adaptation to market shifts
- Technology-driven service differentiation
- Long-term partnership orientation
This approach ensures we outperform competitors and consistently capture high-value opportunities across key sectors.
Mission, Vision, and Core Values
Founded as a focused enterprise, the company has built its strategic market positioning around operational efficiency, customer-centric innovation, and disciplined expansion. It serves mid-to-large clients across multiple regions, leveraging a scalable platform and differentiated service model to compete against larger incumbents and niche specialists. Leadership prioritizes sustainable growth, supply-chain resilience, and digital transformation, supported by partnerships and targeted R&D investment. The firm’s positioning balances premium quality with accessible pricing, strengthening retention and referral rates. To maintain advantage, it monitors competitive shifts, regulatory changes, and emerging technologies, adjusting offerings through data-driven decisions and localized execution, while safeguarding brand trust and long-term profitability.
Registered Capital and Ownership Details
Founded in a garage with little more than a bold idea, the company grew into a trusted market leader by staying true to its founding vision. Its strategic market positioning rests on three pillars:
- Relentless customer focus
- Operational excellence at scale
- Continuous innovation
Today, it competes not on price alone but on experience, carving out a distinct identity in a crowded landscape.
Headquarters Location and Regional Presence
Founded in a garage with little more than a bold idea, the company grew into a trusted name by listening first and selling second. Its strategic market positioning rests on three pillars:
- Premium quality at accessible prices
- Customer-first service culture
- Continuous innovation
Q: What sets it apart? A: A clear promise, kept consistently.
Core Product Portfolio and Therapeutic Areas
A well-structured core product portfolio balances risk across multiple therapeutic areas to sustain long-term growth. Prioritize assets in oncology, immunology, cardiometabolic, and rare disease, where unmet need and pricing power remain strongest. Strategic portfolio diversification reduces reliance on any single molecule, while lifecycle management extends franchise value through new formulations and indications.
Concentrate resources where clinical differentiation, regulatory clarity, and payer acceptance align, not where pipelines are merely crowded.
Evaluate each program against proof of mechanism, competitive density, and real-world evidence potential. A disciplined therapeutic area focus sharpens commercial execution and partnership appeal, turning scientific depth into durable revenue.
Active Pharmaceutical Ingredients (APIs) Offered
Our core product portfolio and therapeutic areas span oncology, immunology, neuroscience, and rare diseases, delivering targeted therapies that address unmet medical needs. Each asset is selected for clinical differentiation, regulatory strength, and commercial potential, ensuring sustained growth across global markets.
- Oncology: precision inhibitors and immuno-oncology agents
- Immunology: biologics for chronic inflammatory conditions
- Neuroscience: CNS therapies with novel mechanisms
- Rare diseases: first-in-class orphan treatments
Q: Why does this portfolio matter? A: It diversifies risk while concentrating expertise where we can lead.
Finished Dosage Forms and Formulations
Our core product portfolio and therapeutic areas span cardiovascular, oncology, immunology, and rare diseases, delivering proven therapies that address unmet medical needs worldwide. Each asset is selected for clinical impact, regulatory strength, and long-term commercial potential. We prioritize innovation that moves science forward while improving patient outcomes.
- Cardiovascular: next-generation anticoagulants and heart failure treatments
- Oncology: targeted therapies and immuno-oncology candidates
- Immunology: biologics for autoimmune and inflammatory conditions
- Rare diseases: precision medicines for underserved populations
This focused portfolio accelerates development, strengthens market access, and builds durable partnerships across the healthcare ecosystem.
Cardiovascular and Metabolic Health Products
Our core product portfolio and therapeutic areas span high-demand specialties including oncology, immunology, cardiometabolic health, and rare diseases. Each therapy is backed by rigorous science and real-world evidence, ensuring clinicians and patients receive reliable, effective solutions. We prioritize innovation where unmet needs are greatest, accelerating access to breakthrough treatments. By focusing on these strategic domains, we deliver measurable outcomes, strengthen partnerships, and drive sustainable growth across global markets.
Anti-Infective and Antimicrobial Solutions
Our core product portfolio and therapeutic areas span high-growth specialties where innovation transforms patient outcomes. From oncology and immunology to neuroscience, cardiometabolic health, and rare diseases, each therapy is engineered for precision, safety, and real-world impact. This focused breadth lets partners and providers access integrated solutions through one trusted source, accelerating development and commercial reach.
- Oncology and immuno-oncology
- Immunology and inflammation
- Neuroscience and pain
- Cardiometabolic and respiratory
- Rare diseases and specialty care
Central Nervous System and Pain Management Lines
Core product portfolios typically concentrate on high-value therapeutic areas where unmet need and reimbursement align. Prioritize assets in oncology, immunology, neuroscience, and rare diseases, as these specialty therapeutic areas often justify premium pricing and faster adoption. Evaluate each program against mechanism differentiation, biomarker strategy, and lifecycle potential. A disciplined portfolio avoids spreading R&D thin across primary care indications with generic competition.
Oncology and Immunology Pipeline Candidates
Our core product portfolio and therapeutic areas span neurology, oncology, immunology, and rare diseases. Each segment includes approved therapies, late-stage candidates, and lifecycle extensions designed to address unmet medical needs. The table below summarizes focus and representative assets.
| Therapeutic Area | Focus | Representative Assets |
|---|---|---|
| Neurology | Neurodegeneration, epilepsy | Small molecules, biologics |
| Oncology | Solid tumors, hematology | Targeted inhibitors, ADCs |
| Immunology | Autoimmune disorders | Monoclonal antibodies |
| Rare Diseases | Genetic disorders | Enzyme replacement therapies |
Q: Why prioritize these therapeutic areas?
A: They offer strong scientific rationale, regulatory pathways, and commercial synergy across the portfolio.
Manufacturing Capabilities and Quality Assurance
Our manufacturing capabilities combine advanced automation with skilled craftsmanship to deliver consistent, high-volume production without compromising precision. From rapid prototyping to full-scale assembly, every process is governed by rigorous quality assurance standards and real-time inspection protocols. We maintain ISO-aligned workflows, traceable material sourcing, and statistical process control to catch deviations before they become defects. This disciplined approach ensures every unit meets exact specifications, reducing waste and accelerating time-to-market. Partner with us for scalable, audit-ready production backed by a zero-defect quality culture that protects your brand and bottom line.
GMP-Certified Production Facilities
Our precision manufacturing capabilities span CNC machining, injection molding, and automated assembly, all managed under a single roof. Every production stage follows ISO-certified protocols, with in-process inspections and final batch testing to catch defects before shipment. Investing in real-time quality data pays for itself through fewer recalls and stronger customer trust. Key assurance measures include:
- Statistical process control on critical dimensions
- Traceability from raw material to finished lot
- Third-party calibration and audit readiness
Advanced Synthesis and Fermentation Technologies
Our precision manufacturing capabilities cover CNC machining, injection molding, sheet metal fabrication, and automated assembly, supported by a network of vetted suppliers and scalable production lines. Quality assurance is integrated at every stage, from incoming material inspection to in-process monitoring and final validation. Key measures include:
- ISO 9001-certified processes
- Statistical process control (SPC)
- Full traceability and documentation
- Dimensional and functional testing
This approach ensures consistent output, reduced defects, and reliable delivery for both low-volume prototypes and high-volume production runs.
Quality Control Laboratories and Analytical Methods
Our precision manufacturing capabilities combine advanced CNC machining, injection molding, and automated assembly lines to deliver components at scale without sacrificing tolerances. Every production run passes through a rigorous quality assurance framework, including:
- Incoming material certification and traceability
- In-process statistical process control (SPC) inspections
- Final dimensional and functional testing
This layered approach catches defects early, reduces waste, and ensures consistent output that meets ISO 9001 and industry-specific standards.
Q: How do you guarantee consistent quality across large orders?
A: Through real-time SPC monitoring, automated optical inspection, and documented corrective-action loops at every stage.
Regulatory Inspections and Compliance Records
Our precision manufacturing capabilities combine CNC machining, injection molding, and automated assembly lines to deliver consistent output at scale. Every production stage is governed by a documented quality management system aligned with ISO 9001 standards, ensuring traceability from raw material to finished goods. Key controls include:
- In-process inspections using calibrated gauges and CMM equipment
- Statistical process control (SPC) to monitor critical tolerances
- Final batch testing with full dimensional and functional reports
This disciplined approach minimizes defects, reduces rework costs, and guarantees that every shipment meets your exact specifications.
Supply Chain Security and Raw Material Sourcing
Our precision manufacturing capabilities span CNC machining, injection molding, and automated assembly, all executed under one roof. Every production run follows validated SOPs, with in-process inspections at critical stages rather than relying on final checks alone. We calibrate equipment on strict schedules and maintain full material traceability from raw stock to finished goods.
Quality is built into the process, not inspected in at the end—prevention always outperforms detection.
- ISO 9001-certified workflows
- Statistical process control on key dimensions
- Documented corrective actions for every deviation
Research, Development, and Innovation
Research, development, and innovation are the engine behind pretty much every cool thing we use today. In simple terms, research is about asking smart questions and digging for answers, while development turns those answers into real products or services. Innovation is the magic step where a fresh idea actually solves a problem or makes life better. Together, R&D and innovation help companies stay ahead, create new jobs, and improve everything from healthcare to your favorite apps. Without a steady push for new ideas, even the biggest brands can quickly fall behind. So yeah, supporting research and development isn’t just for scientists—it’s how we keep moving forward.
In-House R&D Centers and Staff Expertise
Research, Development, and Innovation drive economic growth by transforming ideas into practical solutions. Research and development innovation spans basic science, applied engineering, and market deployment.
Continuous investment in R&D is essential for long-term competitiveness.
Key activities include:
- Basic research to expand knowledge
- Applied development to create prototypes
- Innovation to commercialize new products
Collaborations with Universities and Research Institutes
Effective research, development, and innovation strategy requires disciplined prioritization, not ambition alone. Start by mapping market gaps to internal capabilities, then fund only projects with clear success metrics and kill criteria. Treat R&D as a portfolio: incremental improvements sustain revenue, while breakthrough experiments secure future relevance. Innovation emerges when cross-functional teams share data openly and iterate quickly on validated learning. Protect time for exploratory work, but tie every initiative to customer value or cost advantage. Review quarterly, reallocate ruthlessly, and document failures as assets. This balance turns research into a repeatable engine rather than a cost center.
Patent Portfolio and Intellectual Property Strategy
Research, development, and innovation are the engine behind real progress. In simple terms, research uncovers new knowledge, development turns that knowledge into practical solutions, and innovation brings those solutions to the world in fresh, useful ways. This cycle keeps industries moving, solves everyday problems, and creates better products and services. Whether it’s cleaner energy, smarter tech, or improved healthcare, driving innovation through R&D helps companies stay ahead and communities thrive. It’s not just about big labs—small teams and curious minds make a difference too. When you invest in R&D, you’re really investing in a smarter, more adaptable future for everyone.
Generic Drug Development and 505(b)(2) Pathways
Research, Development, and Innovation drive progress across every industry by turning bold ideas into real-world solutions. RDI strategy for sustainable growth connects scientific discovery with practical application, fueling breakthroughs in technology, medicine, and clean energy.
Innovation is not a single spark—it is a disciplined pipeline from curiosity to impact.
Teams that invest in RDI outperform competitors, adapt faster to change, and unlock new markets. Key pillars include:
- Basic research that expands knowledge
- Applied development that builds prototypes
- Innovation cycles that scale solutions
Novel Drug Delivery Systems and Formulation Science
Research, Development, and Innovation drive economic growth and global competitiveness by transforming ideas into market-ready solutions. Strategic R&D investment fuels breakthroughs in artificial intelligence, biotechnology, and renewable energy. Companies that prioritize innovation outperform competitors, capture new markets, and build resilient futures.
Organizations that embed research and development into their core strategy consistently lead their industries.
- Research generates foundational knowledge.
- Development refines ideas into prototypes.
- Innovation delivers value to customers and society.
Global Market Reach and Export Operations
Taking your business global isn’t just a fancy dream—it’s a smart move that opens doors to millions of new customers. With the right **export operations** in place, you can ship your products to faraway places without the usual headaches. Think about it: local demand might plateau, but worldwide, there’s always someone who needs what you offer. From handling customs paperwork to finding reliable shipping partners, smooth logistics make all the difference. Plus, a strong **global market reach** means your brand gets noticed in places you never imagined. Sure, it takes planning and patience, but the payoff? Way bigger than staying local.
International Distribution Networks
Expanding into international export operations demands more than ambition—it requires disciplined market entry. Prioritize research before shipping: validate demand, tariffs, and compliance in each target region. Build local partnerships to navigate cultural and regulatory nuances, and standardize logistics so delivery stays predictable. Diversify channels to reduce dependency on a single market, and monitor currency exposure closely. Document every step for scalability and audit readiness. Treat each market as its own P&L to catch inefficiencies early and reinvest where margins justify it.
Regulatory Filings with FDA, EMA, and WHO
Global market reach and export operations allow businesses to expand beyond domestic borders, accessing new customers and revenue streams. Effective international export strategy involves navigating trade regulations, logistics, and cultural differences. Companies must assess demand, comply with tariffs, and manage supply chains efficiently. Market entry modes such as direct exporting, licensing, or joint ventures vary by risk and control. Success depends on thorough research, reliable partners, and adaptive pricing. This approach diversifies risk and strengthens competitive positioning worldwide.
Key Export Destinations and Regional Sales Offices
Expanding into international markets transforms local businesses into global contenders, but successful global market reach and export operations demand more than ambition. Companies must navigate customs regulations, currency fluctuations, and logistics networks while adapting products to diverse cultural preferences. A robust export strategy includes:
- Thorough market research and compliance checks
- Reliable freight and distribution partnerships
- Localized pricing and promotional tactics
- Real-time tracking and risk management
By mastering these elements, brands unlock new revenue streams, build resilience, and position themselves as dynamic players on the world stage.
Partnerships with Multinational Pharmaceutical Companies
Taking your business global isn’t as scary as it sounds, and smart export operations make all the difference. You’ll need to handle customs paperwork, shipping logistics, and local regulations, but the payoff is worth it. A few things to keep in mind:
- Research target markets before diving in
- Partner with reliable freight forwarders
- Understand tariffs and trade agreements
Get these right, and your products can reach customers on every continent.
Trade Compliance and Logistics Management
Going global isn’t just a fancy buzzword—it’s how smart businesses grow. With solid export operations, you can ship your products to customers in dozens of countries without losing your mind over paperwork. The trick is understanding local rules, choosing reliable shipping partners, and pricing for different currencies. Get those right, and suddenly your market isn’t your neighborhood—it’s the whole planet. Honestly, the hurdles are real: customs delays, taxes, and cultural quirks. But once you nail the logistics, the payoff is huge. Start small, test one region, then scale up as you learn what works.
Competitive Landscape and Industry Benchmarks
In the bustling marketplace of digital visibility, every brand fights for a seat at the table, yet only a few truly understand where they stand. The competitive landscape reveals rivals’ strengths, pricing tactics, and content gaps, while industry benchmarks quietly whisper the numbers that separate leaders from laggards. Imagine a climber pausing to survey the peak—without that view, every step is guesswork. By tracking metrics like organic traffic, conversion rates, and domain authority, businesses transform raw data into a compass. Mastering SEO performance and competitive intelligence means not just keeping pace, but choosing where to sprint ahead.
Comparison with Domestic Peers in Hubei Province
Understanding the competitive landscape and industry benchmarks is essential for any business aiming to lead rather than follow. Benchmarking against top performers reveals exactly where you stand and what gaps must close.
Companies that rigorously track competitor metrics grow 2.5x faster than those that don’t.
Key areas to monitor include:
- Pricing strategies and margin structures
- Customer acquisition costs and retention rates
- Product innovation cycles and time-to-market
Master these benchmarks, and you don’t just compete—you set the standard others chase.
Differentiation Through Cost and Scale Advantages
Understanding the competitive landscape and industry benchmarks is non-negotiable for sustainable growth. Market leaders consistently outperform laggards by tracking key metrics such as customer acquisition cost, retention rate, and operational efficiency. Without this intelligence, you risk pricing blindly, missing differentiation opportunities, and losing share to agile rivals. Benchmarking against top quartile performers reveals exactly where you stand and what gaps to close. Use these insights to sharpen strategy, prioritize investments, and turn competitive pressure into a decisive advantage that drives measurable results.
Market Share in Specific Therapeutic Segments
Understanding the competitive landscape and industry benchmarks is essential for strategic positioning. Key factors include:
- Market share distribution among top players
- Pricing strategies and cost structures
- Innovation rates and technology adoption
- Customer retention and satisfaction metrics
Benchmarking against industry leaders reveals gaps and opportunities for differentiation.
Regular analysis of these elements helps businesses anticipate shifts and refine their competitive advantage.
SWOT Analysis for Strategic Planning
Understanding the competitive landscape and industry benchmarks is essential for any business aiming to lead rather than follow. By mapping rival strengths, pricing models, and innovation cycles, you expose gaps your brand can own. Benchmarking against top performers turns vague ambition into measurable targets—whether that’s customer retention, cost per acquisition, or margin growth. Winners don’t guess where they stand; they track, compare, and outpace. Use these insights to refine strategy, sharpen positioning, and convert market intelligence into a durable advantage that competitors struggle to copy.
Regulatory Environment and Compliance Standards
Honestly, the regulatory environment and compliance standards can feel like a maze, but they’re basically the rules that keep businesses honest and safe. Depending on your industry, you’ll deal with things like GDPR, HIPAA, or SOX, plus whatever your local government throws in. These legal requirements and data protection laws aren’t just paperwork—they shape how you handle customer info, store records, and report finances. Get it wrong, and you’re looking at fines or lawsuits. Get it right, and you build trust. So yeah, staying compliant isn’t glamorous, but it’s non-negotiable if you want to keep your doors open.
Chinese NMPA Approval History
Navigating the regulatory compliance landscape is non-negotiable for any serious organization. Frameworks such as GDPR, HIPAA, and SOX demand rigorous data governance, transparent reporting, and continuous auditing. Failure to comply invites crippling fines, reputational damage, and lost customer trust. A proactive stance transforms obligations into competitive advantage. Embed compliance into your culture, not just your paperwork. Key pillars include:
- Data privacy and protection mandates
- Industry-specific reporting requirements
- Regular third-party audits and risk assessments
Master these standards, and you build resilience that regulators—and clients—respect.
International GMP Certifications (EU, PIC/S, TGA)
Navigating the regulatory compliance https://stafir.com/company/hubeikornnacpharmace standards is no longer a back-office checkbox—it is the sharp edge of modern business strategy. From GDPR and HIPAA to SOX and PCI-DSS, every framework demands rigorous data governance, transparent reporting, and proactive risk controls. Falling short invites crippling fines, reputational ruin, and lost customer trust.
Compliance is not a cost center—it is a competitive shield that turns legal obligations into market advantage.
- Map every regulation to internal controls
- Automate monitoring and audit trails
- Train teams continuously, not annually
Winning organizations embed compliance into culture, technology, and daily workflows, transforming oversight into resilience and long-term growth.
Environmental, Health, and Safety (EHS) Protocols
Organizations operate within a complex regulatory environment shaped by data protection laws, industry-specific rules, and international standards. A robust compliance management framework helps businesses avoid penalties, protect reputation, and maintain stakeholder trust. Key obligations often include:
- GDPR, CCPA, and similar privacy regulations
- ISO 27001 and SOC 2 security benchmarks
- Sector rules such as HIPAA or PCI DSS
Failure to meet these compliance standards can trigger fines, legal action, or operational restrictions. Effective governance requires continuous monitoring, regular audits, and clear accountability across all departments.
Data Integrity and Pharmacovigilance Systems
Navigating the regulatory compliance landscape demands more than good intentions—it requires disciplined execution. Organizations must adhere to frameworks like GDPR, HIPAA, and SOX, each imposing strict data-handling and reporting obligations. Non-compliance invites fines, litigation, and reputational harm. A proactive approach includes:
- Continuous monitoring of legislative changes
- Regular internal audits and risk assessments
- Mandatory employee training programs
Q: Why prioritize compliance? Because it protects your bottom line and builds lasting stakeholder trust.
Recent Developments and Future Outlook
Recent developments in language technology have accelerated rapidly, with large language models, multimodal systems, and real-time translation tools becoming more accessible across industries. Advances in fine-tuning and retrieval-augmented generation have improved accuracy and contextual understanding, while regulatory frameworks such as the EU AI Act are shaping responsible deployment. Looking ahead, continued innovation is expected in personalized learning, low-resource language support, and human-AI collaboration. However, challenges related to bias, data privacy, and computational cost remain. Overall, the future outlook for language technology points toward more inclusive, efficient, and ethically governed applications, though sustained research and cross-sector cooperation will be essential to realize these benefits.
Expansion Projects and Capital Investments
In 2024, the AI landscape shifted from novelty to necessity, with multimodal models and on-device intelligence transforming daily workflows. Recent developments and future outlook now point toward autonomous agents that plan, reason, and collaborate alongside humans. Yet challenges loom: regulation, energy costs, and trust. Looking ahead, the next wave will likely prioritize transparency and efficiency over raw scale, weaving AI invisibly into healthcare, education, and climate solutions—less a robot uprising, more a quiet revolution that finally keeps its promises.
New Product Launches and Clinical Trials
Recent breakthroughs in generative AI and edge computing are reshaping how enterprises deploy intelligent solutions. Multimodal models now process text, images, and audio in real time, while on-device inference reduces latency and privacy risks. Looking ahead, expect tighter regulation, energy-efficient architectures, and autonomous agent workflows to dominate roadmaps. Organizations that pilot small, domain-specific models today will gain a decisive advantage tomorrow.
Mergers, Acquisitions, and Strategic Alliances
Recent breakthroughs in generative AI, quantum computing, and green hydrogen have accelerated industrial transformation. The future of emerging technologies now hinges on scalable infrastructure and adaptive regulation. Expect rapid gains in edge intelligence and decentralized energy grids. Key near-term priorities include:
- Interoperable AI governance frameworks
- Solid-state battery commercialization
- Post-quantum cryptography adoption
Strategic foresight favors hybrid human-AI workflows over full automation. Invest in modular, resilient systems to hedge against supply chain shocks and talent gaps.
Emerging Trends in Biopharmaceuticals and Biosimilars
In 2025, the race for next-generation AI regulation shifted from debate to deployment. A Brussels policymaker, once buried in draft memos, now watches real-time compliance dashboards light up across three continents. Recent breakthroughs in multimodal models and on-device inference have forced lawmakers to rewrite rules mid-flight, while chipmakers pivot toward energy-efficient architectures. The future belongs not to the fastest builder, but to the most trusted one.
Sustainability Initiatives and Green Chemistry Efforts
Big things are happening in AI, clean energy, and biotech right now, and the pace isn’t slowing down. Companies are rolling out smarter models, cheaper solar storage, and gene-editing breakthroughs faster than ever. Looking ahead, expect tighter regulations, more investment in green tech, and AI woven into everyday tools. The future outlook for emerging technology points to a wild ride—some hype will fade, but real change is coming. Buckle up, stay curious, and keep an eye on what actually ships, not just what gets announced.